United Arab Emirates to review public sector fees for specialised medical care:
This article was originally published in Clinica
The United Arab Emirates is planning to reduce the rates charged for some operations and other specialised medical services in hospitals and health centres if they are found to be higher than private sector charges. So said health minister Humaid Mohammed Obeid Al Qattami, according to national news service Emirates Today. A comparative study of rates charged by public and private hospitals, including recommendations, is to be conducted by a private company and is expected to be complete by the end of the year.
You may also be interested in...
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.